Home SnoreTech Files IPO Prospectus: A Non-Invasive Solution to Combat Snoring and Sleep Apnea

SnoreTech Files IPO Prospectus: A Non-Invasive Solution to Combat Snoring and Sleep Apnea

Jul 14, 2015 08:02 CST Updated 08:02

# Snoring (medically termed as snoring disorder, loud breathing during sleep, or sleep apnea syndrome) is a common sleep phenomenon, so most people consider it a normal physiological sign, and some even believe it indicates deep and restful sleep.

图片1


In fact, from a medical perspective, snoring is a major threat to health. Snoring causes repeated pauses in breathing during sleep, leading to severe hypoxia in the brain and blood, resulting in hypoxemia. This can induce conditions such as hypertension, cardio-cerebral vascular disease, and arrhythmias. Moreover, if nighttime apnea episodes exceed 120 seconds, there is an increased risk of sudden death in the early morning hours.

To this end, a foreign team, SnoreTech, is attempting to “rescue” this group of snorers. Their solution is characterized by the ability to easily stop patients’ snoring without surgery, implants, or CPAP machines.

图片2


SnoreTech: Fun Exercises to Strengthen the Soft Palate Muscles

Unlike other smart anti-snoring products, SnoreTech is an assistive exercise device that enables it to target the deep muscles inside your mouth without any surgery, sound, or electrical stimulation, preventing them from vibrating and thereby stopping snoring.

As an assistive exercise device, SnoreTech’s core objective is to strengthen the patient’s soft palate muscles. Muscle training invariably requires a prolonged and repetitive process, and SnoreTech is no exception. Depending on the severity of the condition, SnoreTech can typically achieve therapeutic success within a period ranging from several months to one year.

The usage method is also quite simple. First, install the “SNOR” app on your smartphone and connect the corresponding device. Then, connect the headphones to the “SNOR” device and insert the tube into the opening on the insertion apparatus. Finally, launch the app to begin the training process!

图片3


Its fundamental principle is that SnoreTech’s external device features a tube that can be inserted into the mouth, with positioning capabilities within the oral cavity. Patients can perform inspiratory muscle training by inhaling in a manner similar to drinking through a straw. The tube should be inserted sufficiently deep; otherwise, the sucking action will be performed by the buccal muscles rather than the soft palate muscles.

图片4


Of course, this training method would be quite monotonous if performed in isolation. Therefore, “SNOR” has established a personalized training program. When patients engage in the training, their muscle activity graphs are displayed on the corresponding smartphone app. This feature allows patients to clearly visualize the results of their efforts, an approach known as “biofeedback.”

图片5


In addition to displaying graphical representations of the patient’s soft palate muscle activity, “SNOR” also incorporates various multimedia stimuli (movies, videos, and images). This allows patients to utilize simple devices and services. Furthermore, “SNOR” can display the patient’s status in real time, enabling review at any moment.

However, the product is still in the R&D phase and is expected to be launched around August.

SnoreTech Team

SnoreTech was developed and designed by a father-son duo. The son, Peter Mikhailenok, serves as CEO/CFO/COO. He holds dual bachelor’s degrees in finance and business administration and previously worked as an investment manager at a financial services firm in Switzerland. The father, Eugene Mikhailenok, is a physician with extensive experience in the healthcare sector. Together, they have assembled a large team of experienced software and hardware R&D engineers to support their product development efforts.

未标题-1


According to VCBeat, the prevalence of sleep disorders in China is as high as 38.2%, with snoring being a major contributing factor. However, due to low public awareness and limited hospital resources, fewer than 0.2% of affected individuals receive treatment. In the United States, approximately 90 million people suffer from snoring, indicating that this market remains profitable.